Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Silke D. Nielsen"'
Autor:
Jesper D. Gunst, Marie H. Pahus, Miriam Rosás-Umbert, I-Na Lu, Thomas Benfield, Henrik Nielsen, Isik S. Johansen, Rajesh Mohey, Lars Østergaard, Vibeke Klastrup, Maryam Khan, Mariane H. Schleimann, Rikke Olesen, Henrik Støvring, Paul W. Denton, Natalie N. Kinloch, Dennis C. Copertino, Adam R. Ward, Winiffer D. Conce Alberto, Silke D. Nielsen, Maria C. Puertas, Victor Ramos, Jacqueline D. Reeves, Christos J. Petropoulos, Javier Martinez-Picado, Zabrina L. Brumme, R. Brad Jones, Julie Fox, Martin Tolstrup, Michel C. Nussenzweig, Marina Caskey, Sarah Fidler, Ole S. Søgaard
Publikováno v:
Gunst, J D, Pahus, M H, Rosás-Umbert, M, Lu, I-N, Benfield, T, Nielsen, H, Johansen, I S, Mohey, R, Østergaard, L, Klastrup, V, Khan, M, Schleimann, M H, Olesen, R, Støvring, H, Denton, P W, Kinloch, N N, Copertino, D C, Ward, A R, Alberto, W D C, Nielsen, S D, Puertas, M C, Ramos, V, Reeves, J D, Petropoulos, C J, Martinez-Picado, J, Brumme, Z L, Jones, R B, Fox, J, Tolstrup, M, Nussenzweig, M C, Caskey, M, Fidler, S & Søgaard, O S 2022, ' Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial ', Nature Medicine, vol. 28, no. 11, pp. 2424-2435 . https://doi.org/10.1038/s41591-022-02023-7
Gunst, J D, Pahus, M H, Rosás-Umbert, M, Lu, I-N, Benfield, T, Nielsen, H, Johansen, I S, Mohey, R, Østergaard, L, Klastrup, V, Khan, M, Schleimann, M H, Olesen, R, Støvring, H, Denton, P W, Kinloch, N N, Copertino, D C, Ward, A R, Alberto, W D C, Nielsen, S D, Puertas, M C, Ramos, V, Reeves, J D, Petropoulos, C J, Martinez-Picado, J, Brumme, Z L, Jones, R B, Fox, J, Tolstrup, M, Nussenzweig, M C, Caskey, M, Fidler, S & Søgaard, O S 2022, ' Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial ', Nature Medicine . https://doi.org/10.1038/s41591-022-02023-7
Gunst, J D, Pahus, M H, Rosás-Umbert, M, Lu, I N, Benfield, T, Nielsen, H, Johansen, I S, Mohey, R, Østergaard, L, Klastrup, V, Khan, M, Schleimann, M H, Olesen, R, Støvring, H, Denton, P W, Kinloch, N N, Copertino, D C, Ward, A R, Alberto, W D C, Nielsen, S D, Puertas, M C, Ramos, V, Reeves, J D, Petropoulos, C J, Martinez-Picado, J, Brumme, Z L, Jones, R B, Fox, J, Tolstrup, M, Nussenzweig, M C, Caskey, M, Fidler, S & Søgaard, O S 2022, ' Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial ', Nature Medicine, vol. 28, no. 11, pp. 2424-2435 . https://doi.org/10.1038/s41591-022-02023-7
Gunst, J D, Pahus, M H, Rosás-Umbert, M, Lu, I-N, Benfield, T, Nielsen, H, Johansen, I S, Mohey, R, Østergaard, L, Klastrup, V, Khan, M, Schleimann, M H, Olesen, R, Støvring, H, Denton, P W, Kinloch, N N, Copertino, D C, Ward, A R, Alberto, W D C, Nielsen, S D, Puertas, M C, Ramos, V, Reeves, J D, Petropoulos, C J, Martinez-Picado, J, Brumme, Z L, Jones, R B, Fox, J, Tolstrup, M, Nussenzweig, M C, Caskey, M, Fidler, S & Søgaard, O S 2022, ' Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial ', Nature Medicine . https://doi.org/10.1038/s41591-022-02023-7
Gunst, J D, Pahus, M H, Rosás-Umbert, M, Lu, I N, Benfield, T, Nielsen, H, Johansen, I S, Mohey, R, Østergaard, L, Klastrup, V, Khan, M, Schleimann, M H, Olesen, R, Støvring, H, Denton, P W, Kinloch, N N, Copertino, D C, Ward, A R, Alberto, W D C, Nielsen, S D, Puertas, M C, Ramos, V, Reeves, J D, Petropoulos, C J, Martinez-Picado, J, Brumme, Z L, Jones, R B, Fox, J, Tolstrup, M, Nussenzweig, M C, Caskey, M, Fidler, S & Søgaard, O S 2022, ' Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1 : a phase 1b/2a, randomized trial ', Nature Medicine, vol. 28, no. 11, pp. 2424-2435 . https://doi.org/10.1038/s41591-022-02023-7
Attempts to reduce the human immunodeficiency virus type 1 (HIV-1) reservoir and induce antiretroviral therapy (ART)-free virologic control have largely been unsuccessful. In this phase 1b/2a, open-label, randomized controlled trial using a four-grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134238a307c4936cfa0d89c5fd761241
https://pubmed.ncbi.nlm.nih.gov/36253609
https://pubmed.ncbi.nlm.nih.gov/36253609
Autor:
Renée M van der Sluis, Lamin B Cham, Albert Gris‐Oliver, Kristine R Gammelgaard, Jesper G Pedersen, Manja Idorn, Ulvi Ahmadov, Sabina Sanches Hernandez, Ena Cémalovic, Stine H Godsk, Jacob Thyrsted, Jesper D Gunst, Silke D Nielsen, Janni J Jørgensen, Tobias Wang Bjerg, Anders Laustsen, Line S Reinert, David Olagnier, Rasmus O Bak, Mads Kjolby, Christian K Holm, Martin Tolstrup, Søren R Paludan, Lasse S Kristensen, Ole S Søgaard, Martin R Jakobsen
Publikováno v:
van der Sluis, R M, Cham, L B, Gris-Oliver, A, Gammelgaard, K R, Pedersen, J G, Idorn, M, Ahmadov, U, Sanches Hernandez, S, Cémalovic, E, Godsk, S H, Thyrsted, J, Gunst, J D, Nielsen, S D, Jørgensen, J J, Wang Bjerg, T, Laustsen, A, Reinert, L S, Olagnier, D, Bak, R O, Kjolby, M, Holm, C K, Tolstrup, M, Paludan, S R, Kristensen, L S, Søgaard, O S & Jakobsen, M R 2022, ' TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection ', The EMBO Journal, pp. e109622 . https://doi.org/10.15252/embj.2021109622
van der Sluis, R M, Cham, L B, Gris-Oliver, A, Gammelgaard, K R, Pedersen, J G, Idorn, M, Ahmadov, U, Hernandez, S S, Cémalovic, E, Godsk, S H, Thyrsted, J, Gunst, J D, Nielsen, S D, Jørgensen, J J, Bjerg, T W, Laustsen, A, Reinert, L S, Olagnier, D, Bak, R O, Kjolby, M, Holm, C K, Tolstrup, M, Paludan, S R, Kristensen, L S, Søgaard, O S & Jakobsen, M R 2022, ' TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection ', EMBO Journal, vol. 41, no. 10, e109622 . https://doi.org/10.15252/embj.2021109622
van der Sluis, R M, Cham, L B, Gris-Oliver, A, Gammelgaard, K R, Pedersen, J G, Idorn, M, Ahmadov, U, Hernandez, S S, Cémalovic, E, Godsk, S H, Thyrsted, J, Gunst, J D, Nielsen, S D, Jørgensen, J J, Bjerg, T W, Laustsen, A, Reinert, L S, Olagnier, D, Bak, R O, Kjolby, M, Holm, C K, Tolstrup, M, Paludan, S R, Kristensen, L S, Søgaard, O S & Jakobsen, M R 2022, ' TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection ', EMBO Journal, vol. 41, no. 10, e109622 . https://doi.org/10.15252/embj.2021109622
Understanding the molecular pathways driving the acute antiviral and inflammatory response to SARS-CoV-2 infection is critical for developing treatments for severe COVID-19. Here, we find decreasing number of circulating plasmacytoid dendritic cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fd30736af2a491a85fdee063fc4b93
https://doi.org/10.15252/embj.2021109622
https://doi.org/10.15252/embj.2021109622
Autor:
Kristine R Gammelgaard, Stine H Godsk, Albert G Olivier, Maria Riedel, Silke D Nielsen, Allard van Renterghem, Trine V Larsen, Anders Etzerodt, Emile Voest, Martin R Jakobsen
Publikováno v:
Cancer Immunology Research. 10:A50-A50
Immunotherapy is a fundamental pillar in the treatment of lung cancer but remains inefficient in half of the treated patients. Recent clinical trials showed synergistic effects of combining chemotherapy and immunotherapy for lung cancer, suggesting t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61e57baa2906dbd3aed88ba9fb202261
https://doi.org/10.1158/2326-6074.tumimm22-a50
https://doi.org/10.1158/2326-6074.tumimm22-a50
Autor:
Jesper Geert Pedersen, Kristine Raaby Gammelgaard, Jakob Thyrsted, Martin Tolstrup, Lamin B Cham, Ole S. Søgaard, Lasse Sommer Kristensen, Tobias W Bjerg, Stine Høvring Godsk, Anders Laustsen, Line S. Reinert, David Olagnier, Søren R. Paludan, Renée M. van der Sluis, Manja Idorn, Janni j Jorgensen, Alberg Gris Oliver, Mads Kjolby, Silke D Nielsen, Sabina Sánchez Hernández, Rasmus O. Bak, Ulvi Ahmodov, Christian K. Holm, Ena Cemalovic, Jesper Damsgaard Gunst, Martin R. Jakobsen
Understanding the molecular pathways driving the acute antiviral and inflammatory response to SARS-CoV-2 infection is critical for developing treatments for severe COVID-19. Here we show that in COVID-19 patients, circulating plasmacytoid dendritic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f776416cf8fa82da3a7207b9af1466a4
https://doi.org/10.1101/2021.11.23.469755
https://doi.org/10.1101/2021.11.23.469755
